Why Shares of BioXcel Therapeutics Are Dropping Thursday
A trial for one of the company's therapies didn't meet its primary endpoint.
Source: fool.com
Stay updated with breaking news from Excited Component. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
A trial for one of the company's therapies didn't meet its primary endpoint.
Hostility can occur in schizophrenia, even in the absence of psychosis. Transdermal asenapine may directly target this symptom.
Dexmedetomidine (Igalmi) reduced agitation in just 20 minutes
Most significant improvement seen with highest asenapine transdermal dose